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Hancock: Healthy Animals, Healthy Humans

Rift Valley fever
Rift Valley fever virus, transmitted by mosquitoes,
causes abortions in cattle, sheep and goats and can
kill young animals. The virus also causes severe
fever in infected animals and can cause fatal illness
in humans, who contract the disease by handling
infected animals or animal products.
Although Rift Valley fever has not reached the U.S., it
has devastated other areas of the world. According to
the World Health Organization, an outbreak earlier
this year killed more than 950 animals in Kenya,
Uganda and Rwanda from June 22 through July 2.
Human deaths reached the double digits. In 2006, the
virus killed 150 people in Kenya.
Ongoing U.S. Department of Homeland Securitysponsored research and training at the K-State
Biosecurity Research Institute is helping develop
and improve vaccines. A team from the K-State
Center of Excellence for Emerging and Zoonotic
Animal Diseases, or CEEZAD, collaborated with U.S.
Department of Agriculture Agricultural Research
Service scientists to develop and patent a safe subunit
vaccine. The vaccine uses only a specific protein from
the virus rather than the whole particle, and the team
has licensed it to a private company. The group also
confirmed that the common native white-tailed deer is
susceptible to infection by the Rift Valley fever virus.
See page 17 for more research on white-tailed deer.

Zoonotic disease research targets maladies
that infect both animals and people
By Sarah Caldwell Hancock
Diseases that spread from animals to people sicken tens of thousands of
Americans each year. Some of these diseases are familiar, such as the flu, and
others are largely unknown in the U.S., such as Rift Valley fever. Some are
transmitted by direct contact with animals, but others are passed along by
mosquitoes or ticks.
All of them are described by the same adjective: zoonotic.

This photo shows mosquito larvae at the mosquito
insectary in the university’s Biosecurity Research
Institute. Mosquitoes are one way that zoonotic
diseases can transmit from animals to humans.

Protecting humans from zoonotic diseases requires understanding the complex
interactions between animal and human health. One concern is that diseases
could spread around the world if the wrong person or animal travels at the
wrong time.
Kansas State University researchers are fighting many of the nation’s and the
world’s most devastating zoonotic diseases.
“K-State research is crucial to national security and public health,” said Peter
Dorhout, K-State vice president for research. “We study several diseases that are
priorities for the National Bio and Agro-defense Facility, and as we do this work,
we are training the workforce needed to provide future biodefense.”
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Rift Valley fever virus can cause fatal illness in humans, who contract
the disease by handling infected animals or animal products. (Photo
credit: CDC/F. A. Murphy; J. Dalrymple)

“Our work is an example of how collaborative
and translational research can result in a tool to
control this devastating disease if it ever comes to
our shores,” said Jürgen Richt, director of CEEZAD
and Regents distinguished professor of veterinary
medicine.
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Japanese encephalitis
Japanese encephalitis virus is a relative of West
Nile virus and is the leading cause of vaccinepreventable brain inflammation in Asia and
the western Pacific, according to the Centers
for Disease Control and Prevention. The
virus thrives in pigs and wading birds and is
transmitted to humans by infected mosquitoes.
Although most infected people do not develop
symptoms, a small percentage experiences
sudden onset of headache, high fever and other
dangerous symptoms. Around 1 in 4 cases is
fatal and a total of about 13,000 to 20,000
people die each year.

Japanese encephalitis virus thrives in pigs and wading birds and is
transmitted to humans by infected mosquitoes. (Photo credit: Sanofi
Pasteur/Alain Grillet)

College of Veterinary medicine researchers
Dana Vanlandingham, associate professor of
diagnostic medicine and pathobiology, and
So Lee Park, third-year veterinary medicine
student and concurrent doctoral student
in pathobiology, recently co-authored a
study demonstrating that North American
domestic pigs could be susceptible to Japanese

Wenjun Ma, associate professor of
diagnostic medicine and pathobiology in
the College of Veterinary Medicine, studies
different strains of influenza, including
highly pathogenic avian influenza and
other strains that can afflict poultry as well
as swine influenza and bat influenza. A
previous collaboration with Jürgen Richt,
Regents distinguished professor of veterinary
medicine, and Mount Sinai Health System
researchers developed a vaccine that easily

Studying foreign animal diseases and
understanding their transmission cycles is
an important step toward preparedness,
Vanlandingham said. The U.S. learned this
lesson the hard way with West Nile virus. Since
1999, West Nile virus has infected five million
people and killed several thousand people.
“This sort of information would have been
useful for past introductions such as West Nile
virus, which is similar to Japanese encephalitis
virus,” Vanlandingham said. “Had we studied
West Nile virus prior to its arrival in the U.S.,
we may have been better able to minimize the
spread when it came into New York in 1999.”
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A resurgence is possible, and K-State
researchers are helping the world prepare.

Zika virus was first identified in monkeys and is spread among humans
by certain mosquito species. (Photo credit: CDC/Cynthia Goldsmith)

Stephen Higgs, director of K-State’s Biosecurity
Research Institute, and Dana Vanlandingham,
associate professor of diagnostic medicine
and pathobiology in the College of Veterinary
Medicine, co-edited a book released earlier this
year, “Chikungunya and Zika Viruses: Global
Emerging Health Threats.” The book provides
both historical and current information on
these important viruses.

“Zika is an example of how quickly something
can emerge,” Higgs said. “It was an obscure
virus that came from Africa and spread rapidly
and widely to more than one million people in
a short time. We were completely unprepared
for it.”
Higgs said K-State and Uniformed Services
University researchers collaborated with the
National Institutes of Health to evaluate new
vaccines against Zika.
The team, along with Yan-Jan S. Huang,
K-State research assistant professor of
arbovirology in the College of Veterinary
Medicine, also co-authored a paper that
discovered a unique antibody effect between
Zika and dengue viruses. So-called crossreactivity may mean that as vaccines for Zika
and dengue are developed and approved,
people need to receive them at the same time to
avoid the antibodies from one virus enhancing
the other, researchers said.

Shiga toxin-producing E. coli
Contaminated food is a major source of
zoonotic disease spread. Most consumers have
heard of Escherichia coli, or E. coli, and know
that it’s something to be avoided, but only a few
strains sicken people. The types that produce
Shiga toxin, known as STEC, can cause illness
with symptoms that include stomach cramps,
diarrhea, vomiting and fever. Some infections
can be life-threatening. STEC strains cause an
estimated 265,000 illnesses in the U.S. each year
according to the Centers for Disease Control
and Prevention, with 36 percent of illnesses
attributed to the worst STEC strain type: O157.

could be delivered to entire poultry flocks to
protect them from multiple avian influenza
strains.
The overall goals of Ma’s research are to
understand why influenza can cross species
barriers and how the viruses are transmitted.
Bat influenza A-like viruses are one of Ma’s
targets. These recently discovered viruses
cause concern because humans and other
species have no immunity against them.
“If a novel virus is able to infect humans
and transmit human to human, it can
cause a pandemic with higher fatality,”
Ma said. “Almost nothing is known about
these viruses. That’s why our research is so
important.”

Influenza virus strains can originate in avian, swine or bat populations
and spread to humans. (Photo credit: CDC/Cynthia Goldsmith;
Jacqueline Katz; Sherif R. Zaki)
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Zika virus was all over the news just two
summers ago, but scientists remain uncertain
about why infections have declined sharply.
This virus is spread by certain mosquito species
and causes potentially fatal birth defects in
babies whose mothers were infected during
pregnancy. Last year, 437 people in the U.S.
were infected with Zika while traveling abroad,
according to the Centers for Disease Control
and Prevention.

encephalitis virus. That means if the virus is
introduced in the U.S., it could take hold and
ultimately infect both pigs and humans. This
research was supported by the U.S. Department
of Agriculture Agricultural Research Service
and its scientists in Manhattan.

Influenza
Coughing co-workers mumble about having
“the flu,” but they may not know that their
illness may have originated in animals. After
the flu, or influenza, makes the initial jump
from animals to humans, humans spread it
quickly through coughs and sneezes.

Zika

Randy Phebus, professor of animal sciences
and industry in the College of Agriculture and
interim director of the Food Science Institute,
said the more than 200 types of STEC are
widely distributed in the environment that
people share with animals; more than 100 have
been linked to human disease.
Validating the effectiveness of commercial
antimicrobial technologies to control STEC

contamination during meat processing is
his area of expertise and the focus of a $25
million U.S. Department of Agriculture grant.
Phebus serves on the grant’s management team
with collaborators from 15 other institutions.
The team recently completed a study on veal
processing. Raw veal poses a substantially
higher STEC risk than beef, according to the
USDA, and Phebus and colleagues have now
validated multiple methods of reducing veal
risks and beef risks in consumer products.
Phebus’ team collaborates with several
processing companies to demonstrate that labgenerated antimicrobial technologies translate
into effective real-world tools. See page 23 for
more on Phebus’ research.
“Working with industry has made this work
really powerful,” Phebus said. “We enhance
public health by giving the food industry proven
antimicrobial intervention technologies to
control STEC and other pathogens on their raw
and processed products.”

Shiga toxin-producing E. coli can infect humans when they eat
contaminated food, such as contaminated beef or veal. (Photo credit:
CDC/Janice Haney Carr)
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